Philip-Joet F - Search Results

1

Carboplatin-etoposide combination in small cell lung cancer patients older than 70 years: a phase II trial.

Larive S, Bombaron P, Riou R, Fournel P, Perol M, Lena H, Dussopt C, Philip-Joet F, Touraine F, Lecaer H, Souquet PJ; Groupe Lyon-Saint Etienne d'Oncologie Thoracique. Larive S, et al. Among authors: philip joet f. Lung Cancer. 2002 Jan;35(1):1-7. doi: 10.1016/s0169-5002(01)00288-4. Lung Cancer. 2002. PMID: 11750705 Review.

2

One-year clinical study on nifedipine in the treatment of pulmonary hypertension in chronic obstructive lung disease.

Vestri R, Philip-Joet F, Surpas P, Arnaud A, Saadjian A. Vestri R, et al. Respiration. 1988;54(2):139-44. doi: 10.1159/000195514. Respiration. 1988. PMID: 3068741 Clinical Trial.

3

Hemodynamic effects of a single dose of dopamine and L-dopa in pulmonary hypertension secondary to chronic obstructive lung disease.

Philip-Joet F, Saadjian A, Vestri R, Tran Guyen A, Arnaud A. Philip-Joet F, et al. Respiration. 1988;53(3):146-52. doi: 10.1159/000195407. Respiration. 1988. PMID: 3420304

4

Philip-Joet F, Bruguerolle B, Parrel M, Vestri R, Arnaud A. Philip-Joet F, et al. Presse Med. 1988 Feb 13;17(5):193-6. Presse Med. 1988. PMID: 2965374 Clinical Trial. French.

5

Hemodynamic effects of bilevel nasal positive airway pressure ventilation in patients with heart failure.

Philip-Joët FF, Paganelli FF, Dutau HL, Saadjian AY. Philip-Joët FF, et al. Respiration. 1999;66(2):136-43. doi: 10.1159/000029355. Respiration. 1999. PMID: 10202317 Clinical Trial.

6

Effects of a constant dose rate of terbutaline on circadian peak expiratory flow, heart rate and systolic arterial pressure in patients with asthma exacerbation.

Philip-Joet F, Bruguerolle B, Lagier F, Pierson F, Reynaud M, Leonardelli M, Orlando JP, Vervloet D, Arnaud A. Philip-Joet F, et al. Respiration. 1992;59(4):197-200. doi: 10.1159/000196058. Respiration. 1992. PMID: 1485003

7

[Acute effects of nicardipine on the vascular reactivity of oxygen in patients with respiratory insufficiency and pulmonary hypertension].

Saadjian A, Philip-Joët F, Paganelli F, Saadjian M, Lévy S. Saadjian A, et al. Arch Mal Coeur Vaiss. 1993 Jun;86(6):899-906. Arch Mal Coeur Vaiss. 1993. PMID: 8274062 Review. French.

8

Long-term treatment of chronic obstructive lung disease by Nifedipine: an 18-month haemodynamic study.

Saadjian AY, Philip-Joet FF, Vestri R, Arnaud AG. Saadjian AY, et al. Eur Respir J. 1988 Aug;1(8):716-20. Eur Respir J. 1988. PMID: 3069486 Clinical Trial.

9

[Long-term treatment of pulmonary hypertension in chronic obstructive bronchopneumopathies with nifedipine. Hemodynamic study over 18 months].

Saadjian A, Philip-Joet F, Vestri R, Arnaud A. Saadjian A, et al. Ann Cardiol Angeiol (Paris). 1989 Apr;38(4):197-202. Ann Cardiol Angeiol (Paris). 1989. PMID: 2735734 Clinical Trial. French.

10

Unequal twice-daily, sustained-release theophylline dosing in chronic obstructive pulmonary disease.

Bruguerolle B, Philip-Joet F, Parrel M, Arnaud A. Bruguerolle B, et al. Chronobiol Int. 1987;4(3):381-5. doi: 10.3109/07420528709083527. Chronobiol Int. 1987. PMID: 3315267 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters